| PERIOD ENDING | 31-Mar-09 | 31-Dec-08 | 30-Sep-08 | 30-Jun-08 | | Total Revenue | 271,966 | 354,910 | 452,415 | 213,147 | | Cost of Revenue | 161,471 | 205,472 | 250,362 | 127,382 | | | Gross Profit | 110,495 | 149,438 | 202,053 | 85,765 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 100,101 | 114,358 | 122,828 | 90,095 | | Non Recurring |
-
| 22,658 | (3,903) |
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 10,394 | 12,422 | 83,128 | (4,330) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 914 | 1,147 | 1,801 | 2,308 | | Earnings Before Interest And Taxes | 11,308 | 13,569 | 84,929 | (2,022) | | Interest Expense |
-
|
-
|
-
| (19) | | Income Before Tax | 11,308 | 13,569 | 84,929 | (2,003) | | Income Tax Expense | 4,410 | (4,988) | 26,600 | (233) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 6,898 | 18,557 | 58,329 | (1,770) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 6,898 | 18,557 | 58,329 | (1,770) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $6,898 | $18,557 | $58,329 | ($1,770) |
|
0.08% Nasdaq 
Income Statement
